White Blood Cell Count and Total and Cause-Specific Mortality in the Women's Health Initiative

Geoffrey C. Kabat, Mimi Kim, Jo Ann E. Manson, Lawrence Lessin, Juan Lin, Sylvia Wassertheil-Smoller, Thomas E. Rohan

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

White blood cell (WBC) count appears to predict total mortality and coronary heart disease (CHD) mortality, but it is unclear to what extent the association reflects confounding by smoking, underlying illness, or comorbid conditions. We used data from the Women's Health Initiative to examine the associations of WBC count with total mortality, CHD mortality, and cancer mortality. WBC count was measured at baseline in 160,117 postmenopausal women and again in year 3 in 74,375 participants. Participants were followed for a mean of 16 years. Cox proportional hazards models were used to estimate the relative mortality hazards associated with deciles of baseline WBC count and of the mean of baseline + year 3 WBC count. High deciles of both baseline and mean WBC count were positively associated with total mortality and CHD mortality, whereas the association with cancer mortality was weaker. The association of WBC count with mortality was independent of smoking and did not appear to be influenced by previous disease history. The potential clinical utility of this common laboratory test in predicting mortality risk warrants further study.

Original languageEnglish (US)
Pages (from-to)63-72
Number of pages10
JournalAmerican Journal of Epidemiology
Volume186
Issue number1
DOIs
StatePublished - Jul 1 2017

Fingerprint

Women's Health
Leukocyte Count
Mortality
Coronary Disease
Smoking
Heart Neoplasms
Proportional Hazards Models

Keywords

  • C-reactive protein
  • cause-specific mortality
  • comorbidity
  • reverse causality
  • smoking
  • total mortality
  • white blood cell count

ASJC Scopus subject areas

  • Epidemiology

Cite this

White Blood Cell Count and Total and Cause-Specific Mortality in the Women's Health Initiative. / Kabat, Geoffrey C.; Kim, Mimi; Manson, Jo Ann E.; Lessin, Lawrence; Lin, Juan; Wassertheil-Smoller, Sylvia; Rohan, Thomas E.

In: American Journal of Epidemiology, Vol. 186, No. 1, 01.07.2017, p. 63-72.

Research output: Contribution to journalArticle

Kabat, Geoffrey C. ; Kim, Mimi ; Manson, Jo Ann E. ; Lessin, Lawrence ; Lin, Juan ; Wassertheil-Smoller, Sylvia ; Rohan, Thomas E. / White Blood Cell Count and Total and Cause-Specific Mortality in the Women's Health Initiative. In: American Journal of Epidemiology. 2017 ; Vol. 186, No. 1. pp. 63-72.
@article{a12c53073b6b468297aa12df37856c26,
title = "White Blood Cell Count and Total and Cause-Specific Mortality in the Women's Health Initiative",
abstract = "White blood cell (WBC) count appears to predict total mortality and coronary heart disease (CHD) mortality, but it is unclear to what extent the association reflects confounding by smoking, underlying illness, or comorbid conditions. We used data from the Women's Health Initiative to examine the associations of WBC count with total mortality, CHD mortality, and cancer mortality. WBC count was measured at baseline in 160,117 postmenopausal women and again in year 3 in 74,375 participants. Participants were followed for a mean of 16 years. Cox proportional hazards models were used to estimate the relative mortality hazards associated with deciles of baseline WBC count and of the mean of baseline + year 3 WBC count. High deciles of both baseline and mean WBC count were positively associated with total mortality and CHD mortality, whereas the association with cancer mortality was weaker. The association of WBC count with mortality was independent of smoking and did not appear to be influenced by previous disease history. The potential clinical utility of this common laboratory test in predicting mortality risk warrants further study.",
keywords = "C-reactive protein, cause-specific mortality, comorbidity, reverse causality, smoking, total mortality, white blood cell count",
author = "Kabat, {Geoffrey C.} and Mimi Kim and Manson, {Jo Ann E.} and Lawrence Lessin and Juan Lin and Sylvia Wassertheil-Smoller and Rohan, {Thomas E.}",
year = "2017",
month = "7",
day = "1",
doi = "10.1093/aje/kww226",
language = "English (US)",
volume = "186",
pages = "63--72",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - White Blood Cell Count and Total and Cause-Specific Mortality in the Women's Health Initiative

AU - Kabat, Geoffrey C.

AU - Kim, Mimi

AU - Manson, Jo Ann E.

AU - Lessin, Lawrence

AU - Lin, Juan

AU - Wassertheil-Smoller, Sylvia

AU - Rohan, Thomas E.

PY - 2017/7/1

Y1 - 2017/7/1

N2 - White blood cell (WBC) count appears to predict total mortality and coronary heart disease (CHD) mortality, but it is unclear to what extent the association reflects confounding by smoking, underlying illness, or comorbid conditions. We used data from the Women's Health Initiative to examine the associations of WBC count with total mortality, CHD mortality, and cancer mortality. WBC count was measured at baseline in 160,117 postmenopausal women and again in year 3 in 74,375 participants. Participants were followed for a mean of 16 years. Cox proportional hazards models were used to estimate the relative mortality hazards associated with deciles of baseline WBC count and of the mean of baseline + year 3 WBC count. High deciles of both baseline and mean WBC count were positively associated with total mortality and CHD mortality, whereas the association with cancer mortality was weaker. The association of WBC count with mortality was independent of smoking and did not appear to be influenced by previous disease history. The potential clinical utility of this common laboratory test in predicting mortality risk warrants further study.

AB - White blood cell (WBC) count appears to predict total mortality and coronary heart disease (CHD) mortality, but it is unclear to what extent the association reflects confounding by smoking, underlying illness, or comorbid conditions. We used data from the Women's Health Initiative to examine the associations of WBC count with total mortality, CHD mortality, and cancer mortality. WBC count was measured at baseline in 160,117 postmenopausal women and again in year 3 in 74,375 participants. Participants were followed for a mean of 16 years. Cox proportional hazards models were used to estimate the relative mortality hazards associated with deciles of baseline WBC count and of the mean of baseline + year 3 WBC count. High deciles of both baseline and mean WBC count were positively associated with total mortality and CHD mortality, whereas the association with cancer mortality was weaker. The association of WBC count with mortality was independent of smoking and did not appear to be influenced by previous disease history. The potential clinical utility of this common laboratory test in predicting mortality risk warrants further study.

KW - C-reactive protein

KW - cause-specific mortality

KW - comorbidity

KW - reverse causality

KW - smoking

KW - total mortality

KW - white blood cell count

UR - http://www.scopus.com/inward/record.url?scp=85024390912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024390912&partnerID=8YFLogxK

U2 - 10.1093/aje/kww226

DO - 10.1093/aje/kww226

M3 - Article

C2 - 28369251

AN - SCOPUS:85024390912

VL - 186

SP - 63

EP - 72

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 1

ER -